Jan Mous, former CSO of Lion Bioscience, has been appointed CEO of genomic-based target discovery firm IntegraGen. Mous will also serve as chairman of the company’s board of directors. Mous left his post as CSO of Lion in January, after holding the position for three years. Prior to that, he spent fifteen years at Roche (Basel, Switzerland), where he was global head of genomics technology and managing director of the genetics/genomics technology platform.
Jul 04, 2003